check_circleStudy Completed
Drugs, Investigational
Bayer Identifier:
15082
ClinicalTrials.gov Identifier:
EudraCT Number:
EU CT Number:
Not Available
Evaluate analgesic efficacy of fast release Aspirin
Trial purpose
The objective of the study is to evaluate the analgesic efficacy of a single, oral dose of fast release aspirin tablets, 650 mg (2 x 325 mg) compared to regular aspirin tablets, 650 mg (2 x 325 mg) and placebo in subjects with postsurgical dental pain.
Key Participants Requirements
Sex
BothAge
16 - 45 YearsTrial summary
Enrollment Goal
500Trial Dates
April 2010 - August 2010Phase
Phase 3Could I Receive a placebo
YesProducts
Bayer Advanced Aspirin (Acetylsalicylic acid, BAY1019036)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Salt Lake City, 84124, United States | |
Completed | Austin, 78705, United States |
Primary Outcome
- Time to First Perceptible Pain Relief (PR)date_rangeTime Frame:0 to 6 hoursenhanced_encryptionNoSafety Issue:
- Time to First Perceptible Pain Relief Confirmeddate_rangeTime Frame:0 to 6 hoursenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Time to meaningful pain reliefdate_rangeTime Frame:0 to 6 hoursenhanced_encryptionNoSafety Issue:
- Pain Intensity at 10, 20, 30, 40, 50, and 60 minutes and at 2, 3, 4, 5, and 6 hours After Dosingdate_rangeTime Frame:10, 20, 30, 40, and 50 minutes and at 1, 2, 3, 4, 5, and 6 hours post-doseenhanced_encryptionNoSafety Issue:
- Pain Intensity Difference (PID) at 10, 20, 30, 40, 50, and 60 minutes and at 2, 3, 4, 5, and 6 hours After Dosingdate_rangeTime Frame:10, 20, 30, 40, 50, and 60 minutes and at 2, 3, 4, 5, and 6 hours post-doseenhanced_encryptionNoSafety Issue:
- Pain Relief at 10, 20, 30, 40, 50, and 60 minutes and at 2, 3, 4, 5, and 6 hours After Dosingdate_rangeTime Frame:10, 20, 30, 40, 50, and 60 minutes and at 2, 3, 4, 5, and 6 hours post-doseenhanced_encryptionNoSafety Issue:
- Summed Pain Intensity Differences (SPID ) from Hour 0 through Hour 2, Hour 4 and Hour 6date_rangeTime Frame:0 - 6 hours post-doseenhanced_encryptionNoSafety Issue:
- Summed Total Pain Relief (TOTPAR ) from Hour 0 through Hour 2, Hour 4 and Hour 6date_rangeTime Frame:0-6 hours post-doseenhanced_encryptionNoSafety Issue:
- Time to First use of Rescue Medicationdate_rangeTime Frame:0 to 6 hoursenhanced_encryptionNoSafety Issue:
- Cumulative Percentage of Subjects Taking Rescue Medicationdate_rangeTime Frame:1, 2, 3, 4, 5, and 6 hours post-doseenhanced_encryptionNoSafety Issue:
- Global Assessment of the Investigational Product as a Pain Reliever at 6 hours After Dosing or Immediately Before the First Intake of Rescue Medicationdate_rangeTime Frame:At 6 hours postdose or immediately before first use of rescue medicationenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Double BlindAssignment
Parallel AssignmentTrial Arms
3Additional Information
Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to Bayer Healthcare products.Click here to find information about studies related to Bayer Healthcare products conducted in Europe